The total cost of HPV-related diseases accounts for €200–250 million of which €210 million is absorbed by the prevention and treatment of precancerous lesions and cervical cancer. Although both available HPV vaccines are below the threshold value for economic convenience (€9,569 and €26,361 per QALY-gained for the quadrivalent and bivalent vaccines, respectively), at this point in time long-term economic models developed for Italy seem to indicate the quadrivalent vaccine as the most cost-effective option. Recent publications by official bodies, including the World Health Organization and the Supervisory Authority for Public Contracts in Italy, recommend that the decision-making process be based on both the quality of goods and services as well as the best achievable price.

Mennini, F.S., Costa, S., Favato, G., & Picardo, M. (2009). Anti-HPV vaccination in Italy: a review of recent economic data for Italy. VACCINE, 27(S1), A54-A61 [10.1016/j.vaccine.2009.02.052].

Anti-HPV vaccination in Italy: a review of recent economic data for Italy

MENNINI, FRANCESCO SAVERIO;
2009-05

Abstract

The total cost of HPV-related diseases accounts for €200–250 million of which €210 million is absorbed by the prevention and treatment of precancerous lesions and cervical cancer. Although both available HPV vaccines are below the threshold value for economic convenience (€9,569 and €26,361 per QALY-gained for the quadrivalent and bivalent vaccines, respectively), at this point in time long-term economic models developed for Italy seem to indicate the quadrivalent vaccine as the most cost-effective option. Recent publications by official bodies, including the World Health Organization and the Supervisory Authority for Public Contracts in Italy, recommend that the decision-making process be based on both the quality of goods and services as well as the best achievable price.
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore SECS-P/03 - Scienza delle Finanze
English
Con Impact Factor ISI
HPV vaccine; cost-effectiveness analysis; economic evaluation; Italy
Mennini, F.S., Costa, S., Favato, G., & Picardo, M. (2009). Anti-HPV vaccination in Italy: a review of recent economic data for Italy. VACCINE, 27(S1), A54-A61 [10.1016/j.vaccine.2009.02.052].
Mennini, Fs; Costa, S; Favato, G; Picardo, M
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/43759
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 19
social impact